<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35514779</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>07</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Print">2045-8932</ISSN>
          <JournalIssue CitedMedium="Print">
            <Volume>12</Volume>
            <Issue>2</Issue>
            <PubDate>
              <Year>2022</Year>
              <Month>Apr</Month>
            </PubDate>
          </JournalIssue>
          <Title>Pulmonary circulation</Title>
          <ISOAbbreviation>Pulm Circ</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Echocardiographic characteristics of patients with antisynthetase syndrome.</ArticleTitle>
        <Pagination>
          <StartPage>e12084</StartPage>
          <MedlinePgn>e12084</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="pii" ValidYN="Y">e12084</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1002/pul2.12084</ELocationID>
        <Abstract>
          <AbstractText>Right ventricular (RV) dysfunction and pulmonary hypertension (PH) occurs in approximately one-third of patients with interstitial lung disease (ILD) and is associated with reduced 6-minute walk distance (6MWD), and increased hospitalizations and mortality. Although the impact of RV dysfunction and PH has been well described in several types of ILD, data is scarce on antisynthetase syndrome. Therefore, we sought to examine the presence of RV dysfunction and PH in patients with antisynthetase syndrome and the impact on clinical outcomes. We conducted a retrospective study of patients with antisynthetase syndrome. Seventy-five subjects were identified. Fifty-one (68%) subjects had echocardiographic data. Patients were grouped into those with normal fractional area change (FAC) ≥ 35% and reduced FAC &lt; 35%. Clinical, echocardiographic, and right heart catheterization data were compared between the two groups. Subjects with FAC &lt; 35% had lower diffusion capacity of the lung for carbon monoxide (29% vs. 47%, <i>p</i> = 0.004), fibrotic features on computed tomography of the chest (79% vs. 33%, <i>p</i> = 0.005), larger RV diameter (5.4 vs. 3.9 cm, <i>p</i> &lt; 0.001), higher right atrial pressures (8 vs. 5 mmHg, <i>p</i> = 0.02), and required supplemental oxygen more frequently (100% vs. 44%, <i>p</i> &lt; 0.001) compared to those with FAC ≥ 35%. We found no difference in 6MWD and hospitalizations between the two groups. The presence of RV dysfunction in antisynthetase syndrome may identify patients at risk of poor outcomes.</AbstractText>
          <CopyrightInformation>© 2022 The Authors. Pulmonary Circulation published by John Wiley &amp; Sons Ltd on behalf of Pulmonary Vascular Research Institute.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Bryan</LastName>
            <ForeName>Jaimie L</ForeName>
            <Initials>JL</Initials>
            <AffiliationInfo>
              <Affiliation>College of Medicine University of Florida Gainesville Florida USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Matar</LastName>
            <ForeName>Ralph</ForeName>
            <Initials>R</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Cardiovascular Medicine University of Florida Gainesville Florida USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Raviprasad</LastName>
            <ForeName>Abheek</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>College of Medicine University of Florida Gainesville Florida USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kuteyeva</LastName>
            <ForeName>Veronica</ForeName>
            <Initials>V</Initials>
            <AffiliationInfo>
              <Affiliation>College of Medicine University of Florida Gainesville Florida USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Milla</LastName>
            <ForeName>Eduardo</ForeName>
            <Initials>E</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Internal Medicine University of Florida Gainesville Florida USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Begateri</LastName>
            <ForeName>Omkar</ForeName>
            <Initials>O</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Internal Medicine University of Florida Gainesville Florida USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Patel</LastName>
            <ForeName>Divya</ForeName>
            <Initials>D</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Pulmonary, Critical Care and Sleep Medicine University of Florida Gainesville Florida USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Manjarres</LastName>
            <ForeName>Diana G</ForeName>
            <Initials>DG</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Pulmonary, Critical Care and Sleep Medicine University of Florida Gainesville Florida USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Kalra</LastName>
            <ForeName>Saminder S</ForeName>
            <Initials>SS</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Pulmonary, Critical Care and Sleep Medicine University of Florida Gainesville Florida USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Robinson</LastName>
            <ForeName>Jeffrey</ForeName>
            <Initials>J</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Pulmonary, Allergy and Critical Care Medicine Oregon Health and Science University Portland Oregon USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Khan</LastName>
            <ForeName>Akram</ForeName>
            <Initials>A</Initials>
            <AffiliationInfo>
              <Affiliation>Division of Pulmonary, Allergy and Critical Care Medicine Oregon Health and Science University Portland Oregon USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Reddy</LastName>
            <ForeName>Raju</ForeName>
            <Initials>R</Initials>
            <Identifier Source="ORCID">0000-0002-3269-0136</Identifier>
            <AffiliationInfo>
              <Affiliation>Division of Pulmonary, Allergy and Critical Care Medicine Oregon Health and Science University Portland Oregon USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>27</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Pulm Circ</MedlineTA>
        <NlmUniqueID>101557243</NlmUniqueID>
        <ISSNLinking>2045-8932</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">antisynthetase syndrome</Keyword>
        <Keyword MajorTopicYN="N">echocardiography</Keyword>
        <Keyword MajorTopicYN="N">pulmonary hypertension</Keyword>
        <Keyword MajorTopicYN="N">right ventricular dysfunction</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no conflicts of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>12</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>12</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>6</Day>
          <Hour>5</Hour>
          <Minute>29</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35514779</ArticleId>
        <ArticleId IdType="pmc">PMC9063959</ArticleId>
        <ArticleId IdType="doi">10.1002/pul2.12084</ArticleId>
        <ArticleId IdType="pii">PUL212084</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>
Strange G, Playford D, Stewart S, Deague JA, Nelson H, Kent A, Gabbay E. Pulmonary hypertension: prevalence and mortality in the Armadale echocardiography cohort. Heart. 2012;98:1805–11. 10.1136/heartjnl-2012-301992
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/heartjnl-2012-301992</ArticleId>
            <ArticleId IdType="pmc">PMC3533383</ArticleId>
            <ArticleId IdType="pubmed">22760869</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Wijeratne DT, Lajkosz K, Brogly SB, Lougheed MD, Jiang L, Housin A, Barber D, Johnson A, Doliszny KM, Archer SL. Increasing incidence and prevalence of World Health Organization Groups 1 to 4 pulmonary hypertension: a population‐based cohort study in Ontario, Canada. Circ Cardiovasc Qual Outcomes. 2018;11:e003973. 10.1161/CIRCOUTCOMES.117.003973
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCOUTCOMES.117.003973</ArticleId>
            <ArticleId IdType="pmc">PMC5819352</ArticleId>
            <ArticleId IdType="pubmed">29444925</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Andersen CU, Mellemkjær S, Hilberg O, Nielsen‐Kudsk JE, Simonsen U, Bendstrup E. Pulmonary hypertension in interstitial lung disease: prevalence, prognosis and 6 min walk test. Respir Med. 2012;106:875–82. 10.1016/j.rmed.2012.02.015
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.rmed.2012.02.015</ArticleId>
            <ArticleId IdType="pubmed">22425136</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Hervier B, Meyer A, Dieval C, Uzunhan Y, Devilliers H, Launay D, Canuet M, Têtu L, Agard C, Sibilia J, Hamidou M, Amoura Z, Nunes H, Benveniste O, Grenier P, Montani D, Hachulla E. Pulmonary hypertension in antisynthetase syndrome: prevalence, aetiology and survival. Eur Respir J. 2013;42:1271–82. 10.1183/09031936.00156312
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/09031936.00156312</ArticleId>
            <ArticleId IdType="pubmed">23397301</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Oswald‐Mammosser M, Weitzenblum E, Quoix E, Moser G, Chaouat A, Charpentier C, Kessler R. Prognostic factors in COPD patients receiving long‐term oxygen therapy. Importance of pulmonary artery pressure. Chest. 1995;107:1193–8. 10.1378/chest.107.5.1193
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.107.5.1193</ArticleId>
            <ArticleId IdType="pubmed">7750305</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest. 2006;129:746–52. 10.1378/chest.129.3.746
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.129.3.746</ArticleId>
            <ArticleId IdType="pubmed">16537877</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Prins KW, Rose L, Archer SL, Pritzker M, Weir EK, Kazmirczak F, Misialek JR, Thenappan T. Disproportionate right ventricular dysfunction and poor survival in group 3 pulmonary hypertension. Am J Respir Crit Care Med. 2018;197:1496–9. 10.1164/rccm.201712-2405LE
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1164/rccm.201712-2405LE</ArticleId>
            <ArticleId IdType="pmc">PMC6005552</ArticleId>
            <ArticleId IdType="pubmed">29360393</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Waxman A, Restrepo‐Jaramillo R, Thenappan T, Ravichandran A, Engel P, Bajwa A, Allen R, Feldman J, Argula R, Smith P, Rollins K, Deng C, Peterson L, Bell H, Tapson V, Nathan SD. Inhaled treprostinil in pulmonary hypertension due to interstitial lung disease. N Engl J Med. 2021;384:325–34. 10.1056/NEJMoa2008470
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMoa2008470</ArticleId>
            <ArticleId IdType="pubmed">33440084</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Galiè N, Humbert M, Vachiery JL, Gibbs S, Lang I, Torbicki A, Simonneau G, Peacock A, Vonk Noordegraaf A, Beghetti M, Ghofrani A, Gomez Sanchez MA, Hansmann G, Klepetko W, Lancellotti P, Matucci M, McDonagh T, Pierard LA, Trindade PT, Zompatori M, Hoeper M, ESC Scientific Document Group
. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37:67–119. 10.1093/eurheartj/ehv317
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/eurheartj/ehv317</ArticleId>
            <ArticleId IdType="pubmed">26320113</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Prins KW, Rose L, Archer SL, Pritzker M, Weir EK, Olson MD, Thenappan T. Clinical determinants and prognostic implications of right ventricular dysfunction in pulmonary hypertension caused by chronic lung disease. J Am Heart Assoc. 2019;8:e011464. 10.1161/JAHA.118.011464
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/JAHA.118.011464</ArticleId>
            <ArticleId IdType="pmc">PMC6497344</ArticleId>
            <ArticleId IdType="pubmed">30646788</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Chatterjee S, Farver C. Severe pulmonary hypertension in Anti‐Jo‐1 syndrome. Arthritis Care Res (Hoboken). 2010;62:425–9. 10.1002/acr.20109
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/acr.20109</ArticleId>
            <ArticleId IdType="pubmed">20391490</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Handa T, Nagai S, Kawabata D, Nagao T, Takemura M, Kitaichi M, Izumi T, Mimori T, Mishima M. Long‐term clinical course of a patient with anti PL‐12 antibody accompanied by interstitial pneumonia and severe pulmonary hypertension. Intern Med. 2005;44:319–25. 10.2169/internalmedicine.44.319
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2169/internalmedicine.44.319</ArticleId>
            <ArticleId IdType="pubmed">15897644</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Hervier B, Uzunhan Y, Hachulla E, Benveniste O, Nunes H, Delaval P, Musset L, Dubucquoi S, Wallaert B, Hamidou M. Antisynthetase syndrome positive for anti‐threonyl‐tRNA synthetase (anti‐PL7) antibodies. Eur Respir J. 2011;37:714–7. 10.1183/09031936.00104310
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/09031936.00104310</ArticleId>
            <ArticleId IdType="pubmed">21357927</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Connors GR, Christopher‐Stine L, Oddis CV, Danoff SK. Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years?
Chest. 2010;138:1464–74. 10.1378/chest.10-0180
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1378/chest.10-0180</ArticleId>
            <ArticleId IdType="pubmed">21138882</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Solomon J, Swigris JJ, Brown KK. Myositis‐related interstitial lung disease and antisynthetase syndrome. J Bras Pneumol. 2011;37:100–9. 10.1590/s1806-37132011000100015
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1590/s1806-37132011000100015</ArticleId>
            <ArticleId IdType="pmc">PMC3676869</ArticleId>
            <ArticleId IdType="pubmed">21390438</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
American Thoracic Society and European Respiratory Society
. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med. 2002;165:277–304. 10.1164/ajrccm.165.2.ats01
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1164/ajrccm.165.2.ats01</ArticleId>
            <ArticleId IdType="pubmed">11790668</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Terpenning S, Deng M, Hong‐Zohlman SN, Lin CT, Kligerman SJ, Jeudy J, Ketai LH. CT measurement of central pulmonary arteries to diagnose pulmonary hypertension (PHTN): more reliable than valid?
Clin Imaging. 2016;40:821–7. 10.1016/j.clinimag.2016.02.024
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.clinimag.2016.02.024</ArticleId>
            <ArticleId IdType="pubmed">27131412</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
NHANESIII
. https://www.cdc.gov/niosh/topics/spirometry/nhanes.html
</Citation>
        </Reference>
        <Reference>
          <Citation>
Brooks D, Solway S, Gibbons WJ. ATS statement on six‐minute walk test. Am J Respir Crit Care Med. 2003;167:1287. 10.1164/ajrccm.167.9.950
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1164/ajrccm.167.9.950</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Lang RM, Badano LP, Mor‐Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28:1–39. 10.1016/j.echo.2014.10.003
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.echo.2014.10.003</ArticleId>
            <ArticleId IdType="pubmed">25559473</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Papolos A, Tison GH, Mayfield J, Vasti E, DeMarco T. Echocardiographic assessment of pulmonary arterial capacitance predicts mortality in pulmonary hypertension. J Cardiol. 2021;77:279–84. 2020/11/08. 10.1016/j.jjcc.2020.10.006
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jjcc.2020.10.006</ArticleId>
            <ArticleId IdType="pmc">PMC8452137</ArticleId>
            <ArticleId IdType="pubmed">33158713</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, Solomon SD, Louie EK, Schiller NB. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010;23:685–713. 10.1016/j.echo.2010.05.010
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.echo.2010.05.010</ArticleId>
            <ArticleId IdType="pubmed">20620859</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
LaFarge CG, Miettinen OS. The estimation of oxygen consumption. Cardiovasc Res. 1970;4:23–30. 10.1093/cvr/4.1.23
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cvr/4.1.23</ArticleId>
            <ArticleId IdType="pubmed">5416840</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Evaldsson AW, Lindholm A, Jumatate R, Ingvarsson A, Smith GJ, Waktare J, Rådegran G, Roijer A, Meurling C, Ostenfeld E. Right ventricular function parameters in pulmonary hypertension: echocardiography vs. cardiac magnetic resonance. BMC Cardiovasc Disord. 2020;20:259. 10.1186/s12872-020-01548-4
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12872-020-01548-4</ArticleId>
            <ArticleId IdType="pmc">PMC7268227</ArticleId>
            <ArticleId IdType="pubmed">32487063</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Nathan SD, Barbera JA, Gaine SP, Harari S, Martinez FJ, Olschewski H, Olsson KM, Peacock AJ, Pepke‐Zaba J, Provencher S, Weissmann N, Seeger W. Pulmonary hypertension in chronic lung disease and hypoxia. Eur Respir J. 2019;53:1801914. 10.1183/13993003.01914-2018
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1183/13993003.01914-2018</ArticleId>
            <ArticleId IdType="pmc">PMC6351338</ArticleId>
            <ArticleId IdType="pubmed">30545980</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Cobra SB, Rodrigues MP, de Melo FX, Ferreira N, Passini VV, Amado VM, Melo‐Silva CA. Right ventricular dysfunction in patients with non‐severe idiopathic pulmonary fibrosis: a cross‐sectional prospective single‐center study. Expert Rev Respir Med. 2021;15:249–56. 10.1080/17476348.2021.1834856
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1080/17476348.2021.1834856</ArticleId>
            <ArticleId IdType="pubmed">33070645</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kolb TM, Hassoun PM. Right ventricular dysfunction in chronic lung disease. Cardiol Clin. 2012;30:243–56. 10.1016/j.ccl.2012.03.005
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ccl.2012.03.005</ArticleId>
            <ArticleId IdType="pmc">PMC3342531</ArticleId>
            <ArticleId IdType="pubmed">22548815</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Alzghoul BN, Hamburger R, Lewandowski T, Janssen B, Grey D, Xue W, Ataya A, Alnuaimat H, Gomez‐Manjarres DC, Patel D, Reddy R. Pulmonary hypertension in patients with interstitial pneumonia with autoimmune features. Pulm Circ. 2020;10:2045894020944117. 10.1177/2045894020944117
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/2045894020944117</ArticleId>
            <ArticleId IdType="pmc">PMC7727068</ArticleId>
            <ArticleId IdType="pubmed">33343878</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Hoette S, Creuzé N, Günther S, Montani D, Savale L, Jaïs X, Parent F, Sitbon O, Rochitte CE, Simonneau G, Humbert M, Souza R, Chemla D. RV fractional area change and TAPSE as predictors of severe right ventricular dysfunction in pulmonary hypertension: a CMR study. Lung. 2018;196:157–64. 10.1007/s00408-018-0089-7
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00408-018-0089-7</ArticleId>
            <ArticleId IdType="pubmed">29435740</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Papakosta D, Pitsiou G, Daniil Z, Dimadi M, Stagaki E, Rapti A, Antoniou K, Tzouvelekis A, Kontakiotis T, Tryfon S, Polychronopoulos V, Bouros D. Prevalence of pulmonary hypertension in patients with idiopathic pulmonary fibrosis: correlation with physiological parameters. Lung. 2011;189:391–9. 10.1007/s00408-011-9304-5
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00408-011-9304-5</ArticleId>
            <ArticleId IdType="pubmed">21660584</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Yan W, Peng LY, Ban CJ, Xu XF, Zhu M, Liu Y, Zhang S, Zhai ZG, Wang C, Dai HP. Incidence and clinical characteristics of pulmonary hypertension in patients with idiopathic pulmonary fibrosis. Chin Med J (Engl). 2015;128:896–901. 10.4103/0366-6999.154284
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4103/0366-6999.154284</ArticleId>
            <ArticleId IdType="pmc">PMC4834005</ArticleId>
            <ArticleId IdType="pubmed">25836609</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Barbasso Helmers S, Englund P, Engström M, Ahlin E, Fathi M, Janciauskiene S, Heimbürger M, Rönnelid J, Lundberg IE. Sera from anti‐Jo‐1‐positive patients with polymyositis and interstitial lung disease induce expression of intercellular adhesion molecule 1 in human lung endothelial cells. Arthritis Rheum. 2009;60:2524–30. 10.1002/art.24683
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/art.24683</ArticleId>
            <ArticleId IdType="pubmed">19644880</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Kuebler WM, Bonnet S, Tabuchi A. Inflammation and autoimmunity in pulmonary hypertension: is there a role for endothelial adhesion molecules? (2017 Grover Conference Series). Pulm Circ. 2018;8:2045893218757596. 10.1177/2045893218757596
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/2045893218757596</ArticleId>
            <ArticleId IdType="pmc">PMC5865459</ArticleId>
            <ArticleId IdType="pubmed">29480134</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>
Coghlan JG, Denton CP, Grünig E, Bonderman D, Distler O, Khanna D, Müller‐Ladner U, Pope JE, Vonk MC, Doelberg M, Chadha‐Boreham H, Heinzl H, Rosenberg DM, McLaughlin VV, Seibold JR, DETECT study g. Evidence‐based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study. Ann Rheum Dis. 2014;73:1340–49. 10.1136/annrheumdis-2013-203301
</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/annrheumdis-2013-203301</ArticleId>
            <ArticleId IdType="pmc">PMC4078756</ArticleId>
            <ArticleId IdType="pubmed">23687283</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
